These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16247001)

  • 1. The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation.
    Lee LF; Xu B; Michie SA; Beilhack GF; Warganich T; Turley S; McDevitt HO
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15995-6000. PubMed ID: 16247001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
    Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
    J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.
    Wu AJ; Hua H; Munson SH; McDevitt HO
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12287-92. PubMed ID: 12221281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
    Lee MH; Lee WH; Todorov I; Liu CP
    J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.
    Machen J; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
    J Immunol; 2004 Oct; 173(7):4331-41. PubMed ID: 15383562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced numbers of dendritic cells with a tolerogenic phenotype in the prediabetic pancreas of NOD mice.
    Welzen-Coppens JM; van Helden-Meeuwsen CG; Leenen PJ; Drexhage HA; Versnel MA
    J Leukoc Biol; 2012 Dec; 92(6):1207-13. PubMed ID: 23012431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment.
    Layseca-Espinosa E; Korniotis S; Montandon R; Gras C; Bouillié M; Gonzalez-Amaro R; Dy M; Zavala F
    J Immunol; 2013 Sep; 191(5):2266-72. PubMed ID: 23878314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gene expression profile of CD11c+ CD8α- dendritic cells in the pre-diabetic pancreas of the NOD mouse.
    Beumer W; Welzen-Coppens JM; van Helden-Meeuwsen CG; Gibney SM; Drexhage HA; Versnel MA
    PLoS One; 2014; 9(8):e103404. PubMed ID: 25166904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of neonatal BCG vaccination on phenotype and function of splenic dendritic cells of BALB/c mice].
    Liu CH; Liu EM; Liu CH; Liu W; Yang XQ; Li X
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):784-8. PubMed ID: 19099886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes.
    Chen YG; Choisy-Rossi CM; Holl TM; Chapman HD; Besra GS; Porcelli SA; Shaffer DJ; Roopenian D; Wilson SB; Serreze DV
    J Immunol; 2005 Feb; 174(3):1196-204. PubMed ID: 15661873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells.
    Kriegel MA; Rathinam C; Flavell RA
    Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3457-62. PubMed ID: 22328150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8alpha+ dendritic cells enhance the antigen-specific CD4+ T-cell response and accelerate development of collagen-induced arthritis.
    Jung YO; Min SY; Cho ML; Park MJ; Jeon JY; Lee JS; Oh HJ; Kang CM; Park HS; Park KS; Cho SG; Park SH; Kim HY
    Immunol Lett; 2007 Aug; 111(2):76-83. PubMed ID: 17610959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MerTK is required for apoptotic cell-induced T cell tolerance.
    Wallet MA; Sen P; Flores RR; Wang Y; Yi Z; Huang Y; Mathews CE; Earp HS; Matsushima G; Wang B; Tisch R
    J Exp Med; 2008 Jan; 205(1):219-32. PubMed ID: 18195070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice.
    Vasquez AC; Feili-Hariri M; Tan RJ; Morel PA
    Clin Exp Immunol; 2004 Feb; 135(2):209-18. PubMed ID: 14738447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interferon alpha in initiation of type I diabetes in the NOD mouse.
    Li Q; McDevitt HO
    Clin Immunol; 2011 Jul; 140(1):3-7. PubMed ID: 21592863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
    Radosevic K; Casteels KM; Mathieu C; Van Ewijk W; Drexhage HA; Leenen PJ
    J Autoimmun; 1999 Dec; 13(4):373-82. PubMed ID: 10585753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
    J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.
    Schloss J; Ali R; Babad J; Guerrero-Ros I; Pongsachai J; He LZ; Keler T; DiLorenzo TP
    Immunohorizons; 2019 Jun; 3(6):236-253. PubMed ID: 31356169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.